News & Articles

Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing

Digital PCR for COVID-19 wastewater testing overcomes limitations of traditional PCR

QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.

Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, aims to provide accurate results in less than 15 minutes

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies

The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes

QIAGEN launches therascreen PIK3CA RGQ PCR Kit in Europe

Japan selects QIAGEN Clinical Insight-Interpret to handle next-generation sequencing data

Agreement adds commercial firepower for QIAGEN’s U.S. launch of the next-generation platform for syndromic insights initially for respiratory conditions

QIAGEN becomes exclusive partner for bioinformatics research applications based on ARESdb and AREStools

Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System

aLF Reader and ImplantSafeDR test accurately detect damaging inflammation earlier than traditional methods to better protect dental implants